|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/22 | |
| A61P 35/00 |
| (11) | Patento numeris | 2059254 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07841411.7 |
| Europos patento paraiškos padavimo data | 2007-08-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-04-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/076903 |
| Data | 2007-08-27 |
| (87) | Numeris | WO 2008/027839 |
| Data | 2008-03-06 |
| (30) | Numeris | Data | Šalis |
| 824197 P | 2006-08-31 | US |
| (72) |
GULATI, Anil, US
REDDY, Guru, US
LENAZ, Luigi, US
|
| (73) |
Spectrum Pharmaceuticals, Inc.,
157 Technology Drive, Irvine, CA 92618,
US
The Board of Trustees of the University of Illinois, 352 Henry Administration Building 506 South Wright Street, Urbana Illinois 61801, US |
| (54) | SENSITIZATION OF TUMOR CELLS TO RADIATION THERAPY THROUGH THE ADMINISTRATION OF ENDOTHELIN AGONISTS |
| SENSITIZATION OF TUMOR CELLS TO RADIATION THERAPY THROUGH THE ADMINISTRATION OF ENDOTHELIN AGONISTS |